Quick Take:

  • Silo Wellness Inc. announced a series of psilocybin-assisted wellness retreats beginning in May. Based in Montego Bay.
  • These retreats are one component of Silo Wellness’ existing psilocybin operations in Jamaica.

Silo Wellness Inc., a leading wellness company in the psychedelics and functional mushroom marketplaces, today announced a series of psilocybin-assisted wellness retreats beginning in May. Based in Montego Bay, these retreats are one component of Silo Wellness’ existing psilocybin operations in Jamaica, where the Company currently conducts mushroom and truffle cultivation and testing of the Company’s patent-pending nasal spray.

“We are prioritizing the expansion of our wellness retreat offerings to meet rising consumer demand for these transformative psychedelic experiences. Setting and mindset have a profound influence on an individual’s experience, and our Jamaican retreats offer idyllic, natural backdrops for engaging in psilocybin-assisted exploration, introspection and self-actualization.”

Douglas K. Gordon – Chief Executive Officer of Silo Wellness Inc.

The new line-up of psilocybin-assisted retreats range from four to six days and are expected to take place in Jamaica between May and August of 2021. Each retreat presents a tailored offering for distinct audiences and interests:

Silo Wellness is the leading psilocybin cultivator and facilitator of psychedelic retreats in Jamaica, a jurisdiction where the cultivation, extraction, and consumption of psilocybin mushrooms is not illegal.

For more information about Silo Wellness psychedelic retreats, or to register, visit https://www.silowellness.com/retreats. Each registration is subject to screening and approval by facilitators, and no medical treatment or psychotherapy is offered or available at the retreat. Mushrooms and these retreats do not cure or mitigate any physical or mental disease, symptoms, disorders, or abnormalities.

ABOUT SILO WELLNESS

The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion. Silo Wellness intends to introduce new, safe, and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal by conducting ketamine and psilocybin wellness retreats and elsewhere by manufacturing and distributing functional mushrooms.

Since its inception, Silo Wellness’ activities have focused on: (1) development of psilocybin-free functional mushroom tinctures; (2) the development of the formulation of a psilocybin nasal spray in Jamaica; and (3) offering of Jamaican and Oregon psychedelic wellness retreats as well as the cultivation of psychedelic mushrooms in Jamaica. None of Silo Wellness’s products claim to cure or mitigate any physical or mental disease, symptoms, disorders, or abnormalities.

For further information, please contact:

Media Relations:
Stuart Kirby, VP of Marketing & Communications 
press@silowellness.com

Silo Wellness Investor Relations:
(604) 343-2724
IR@empiregroupir.com